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Apoptosis,	programmed	cell	death,	plays	important	
role	 in	controlling	cells	 fate	 in	normal	physiological	
state	and	upon	carcinogenesis	 [4,	 5,	 12].	Several	
genes’	products	have	been	demonstrated	to	be	critical	
in	the	regulation	of	apoptosis.	Caspases	are	essential	
for	the	execution	of	cell	death	upon	various	apoptotic	
stimuli	[20].
Caspase	activation	 is	often	 regulated	by	various	
cellular	proteins,	 including	members	of	the	 inhibitor	
of	apoptosis	protein	(IAP),	the	Bcl-2	family	and/or	the	
Fas/FasL	system	[4,	5,	13,	18].	Emerging	evidence	
has	demonstrated	that	anticancer	activities	of	certain	
chemotherapeutic	agents	are	involved	in	the	induction	
of	apoptosis,	which	is	regarded	as	the	preferred	way	
to	manage	cancer	[4,	12].
β-lapachone	(3,4-dihydro-2,2-dimenthyl-2H-nap-
thol	 [1,2-b]pyran-5,6-dione)	 is	natural	plant	quinone	
obtained	from	the	bark	of	 the	 lapacho	tree	(Tabebuia 
avellanedae)	which	 is	native	 to	South	America	 [21].	
This	compound	inhibits	reverse	transcriptase	and	DNA	
polymerase-α,	and	blocks	DNA	repair	thus	sensitizing	
tumor	cells	to	DNA	—	damaging	agents	[2,	21].	Several	
studies	suggested	that	β-lapachone	could	directly	target	
DNA	topoisomerases	and	inhibit	their	activity	[8,	15,	16].	
However,	its	inhibitory	mode	is	distinct	from	that	of	other	
typical	topoisomerase	inhibitors,	such	as	camptothecin	
and	 related	compounds	 [15].	β-lapachone	exhibits	
anti-bacterial,	anti-fungal	and	anti-trypanocidal	action	
[10,	11,	17],	which	are	linked	to	the	formation	of	reactive	
oxygen	species	[7,	19].	In	addition,	it	has	been	known	
that	β-lapachone	induces	apoptotic	cell	death	in	human	
cancer	cells,	however,	the	molecular	mechanisms	of	its	
anti-proliferative	action	are	not	known	completely.
In	 this	study	we	determined	 the	antiproliferative	
activity	of	β-lapachone,	and	examined	 its	effect	on	
apoptosis	 in	 the	human	bladder	carcinoma	cell	 line	
T24.	Furthermore,	to	establish	the	anticancer	mecha-
nism	of	β-lapachone,	we	assayed	the	levels	of	several	
important	genes,	which	are	strongly	associated	with	
apoptosis	and	influence	the	sensitivity	of	tumor	cells	
to	anticancer	agents.
MATERIALS AND METHODS
Cell culturing.	Human	bladder	carcinoma	cell	line	
T24	was	purchased	from	the	American	Type	Culture	
Collection	 (Rockville,	USA),	 and	cultured	 in	RPMI	
1640	medium	supplemented	with	10%	heat-inacti-
vated	fetal	bovine	serum	(FBS),	2	mM	L-glutamine,	
100	µg/mL	streptomycin,	and	100	µg/mL	penicillin	
(Gibco	BRL,	USA)	at	37	°C	and	5%	CO2.	β-lapachone	
was	purchased	from	Biomol	(Plymouth	Meeting,	PA,	
USA)	and	dissolved	 in	 ice-cold	absolute	alcohol	as	
a	stock	solution	at	10	mM	concentration,	and	stored	
in	aliquots	at	–20	°C.	Cells	were	cultured	 in	 the	ab-
sence	and	presence	of	 variable	concentrations	of	
β-lapachone	for	48	h,	then	trypsinized,	washed	with	
phosphate-buffered	saline	(PBS),	and	the	viable	cells	
were	scored	using	hemocytometer	and	the	exclusion	
of	trypan	blue.	
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Nuclear	staining	with	DAPI. Cells	were	washed	with	
cold	PBS	and	 fixed	with	3.7%	paraformaldehyde	 in	
PBS	for	10	min	at	room	temperature.	Fixed	cells	were	
washed	with	PBS,	and	stained	with	4,	6-diamidino-
2-phenylindile	 (DAPI,	 Sigma	Chemical	Co.,	USA)	
solution	 for	10	min	at	 room	 temperature.	The	cells	
were	washed	two	more	times	with	PBS	and	analyzed	
by	fluorescent	microscopy.	
DNA fragmentation assay. After	treatment	with	
β-lapachone,	cells	were	lysed	in	a	buffer	containing	
10	mM	Tris-HCl	(pH	7.4),	150	mM	NaCl,	5	mM	EDTA	
and	0.5%	Triton	X-100	for	30	min	on	ice.	Lysates	were	
vortexed	and	cleared	by	centrifugation	at	10.000	g	
for	20	min.	Fragmented	DNA	in	the	supernatant	was	
extracted	with	an	equal	 volume	of	neutral	phenol	 :	
chloroform	 :	 isoamylalcohol	 (25	 :	24	 :	1,	 v/v/v)	and	
analyzed	electrophoretically	on	1%	agarose	gel	con-
taining	ethidium	bromide	(EtBr,	Sigma).
Flow cytometry assay. After	 treatment	with	β-
lapachone,	cells	were	collected,	washed	with	cold	
PBS,	and	resuspended	in	PBS.	DNA	contents	of	cells	
were	measured	using	a	DNA	staining	kit	(CycleTESTTM	
PLUS	Kit,	Becton	Dickinson,	USA).	Propidium	iodide	
(PI)	—	stained	nuclear	 fractions	were	obtained	by	
following	the	kit	protocol.	Fluorescence	intensity	was	
determined	using	a	FACScan	flow	cytometer	and	ana-
lyzed	by	CellQuest	software	(Becton	Dickinson).
RNA extraction and RT-PCR. Total	RNA	was	
isolated	according	to	the	method	[3].	Single-stranded	
cDNA	was	synthesized	from	2	µg	of	total	RNA	using	
M-MLV	reverse	transcriptase	(Gibco	BRL).	The	mRNAs	
were	amplified	by	polymerase	chain	 reaction	 (PCR)	
with	desired	primers	(see	Table).	Conditions	for	PCR	
reaction	were	1	х	 (94	 °C,	3	min);	35	х	 (94	 °C,	45	s;	
58	°C,	45	s;	and	72	°C,	1	min)	and	1	х	(72	°C,	10	min).	
Amplification	products	obtained	by	PCR	were	electro-
phoretically	separated	on	1%	agarose	gel.
Table 1. Gene-specific primers for RT-PCR
Name Sequence of primers
Bax sence 5΄-ATG-GAC-GGG-TCC-GGG-GAG-3΄
antisence 5΄-TGG-AAG-AAG-ATG-GGC-TGA-3΄
Bcl-2 sence 5΄-CAG-CTG-CAC-CTG-ACG-3΄
antisence 5΄-GCT-GGG-TAG-GTG-CAT-3΄
Bcl-XL sence 5΄-CAG CTG CAC CTG ACG-3΄
antisence 5΄-GCT GGG TAG GTG CAT-3΄
XIAP sence 5΄-GAA-GAC-CCT-TGG-GAA-CAA-CA-3΄
antisence 5-CGC-CTT-AGC-TGC-TCT-CTT-CAG-T-3΄ 
cIAP-1 sence 5΄-TGA-GCA-TGC-AGA-CAC-ATG-C-3΄
antisence 5΄-TGA-CGG-ATG-AAC-TCC-TGT-CC-3΄
cIAP-2 sence 5΄-CAG-AAT-TGG-CAA-GAG-CTG-G-3΄
antisence 5΄-CAC-TTG-CAA-GCT-GCT-CAG-G-3΄
Fas sence 5΄-TCT-AAC-TTG-GGG-TGG-CTT-TGT-CTT-C-3΄
antisence 5΄-GTG-TCA-TAC-GCT-TTC-TTT-CCA-T-3΄
Fas sence 5΄-GGA-TTG-GGC-CTG-GGG-ATG-TTT-CA-3΄
antisence 5΄AGC-CCA-GTT-TCA-TTG-ATC-ACA-AGG-3΄
GAPDH sence 5΄-CGG-AGT-CAA-CGG-ATT-TGG-TCG-TAT-3΄
antisence 5΄-AGC-CTT-CTC-CAT-GGT-GGT-GAA-GAC-3΄
Gel electrophoresis and Western blot analysis. 
The	cells	were	harvested,	lyzed,	and	protein	concen-
trations	were	measured	using	 the	Bio	Rad	protein	
assay	 (BioRad	Lab.,	USA),	according	 to	protocol	of	
manufacturer.	An	equal	amount	of	protein	was	subject-
ed	to	electrophoresis	on	SDS-polyacrylamide	gels	and	
transferred	to	nitrocellulose	membranes	(Schleicher	&	
Schuell,	USA)	by	electroblotting.	Blots	were	incubated	
with	the	desired	antibodies	for	1	h,	incubated	with	di-
luted	enzyme-linked	secondary	antibodies,	and	then	
visualized	by	the	enhanced	chemiluminescence	(ECL)	
according	to	the	recommended	procedure	(Amersham	
Corp.,	USA).	The	primary	antibodies	were	purchased	
from	Santa	Cruz	Biotechnology	 Inc.	 (USA).	Peroxi-
dase-labeled	donkey	anti-rabbit	immunoglobulin	and	
peroxidase-labeled	sheep	anti-mouse	immunoglobu-
lin	were	purchased	from	Amersham.	
In vitro caspase activity assay. Caspases	activity	
was	determined	by	colorimetric	assay	using	the	cas-
pase-3	and	caspase-9	activation	kits	 from	Clontech	
Lab.	 (USA)	and	R&D	Systems	 (USA),	 respectively,	
following	the	manufacturer’s	protocol.	The	kits	used	in	
the	present	study	utilize	synthetic	tetrapeptides,	DEVD	
for	caspase-3	and	LEHD	for	caspase-9,	 labeled	with	
p-nitroaniline	(pNA).	Briefly,	β-lapachone-treated	and	
untreated	cells	were	lyzed	in	the	supplied	lysis	buffer.	
The	supernatants	were	collected	and	 incubated	with	
the	supplied	 reaction	buffer	containing	dithiothreitol	
and	substrates	at	37	°C.	The	reaction	was	measured	by	
changes	in	absorbance	at	405	nm	using	the	VERSAmax	
tunable	microplate	reader	(Molecular	devices,	USA).
RESULTS AND DISCUSSION
Inhibition of viability and induction of apop-
tosis by β-lapachone. Cells	were	cultured	 in	10%	
FBS-containing	medium,	with	or	without	β-lapachone	
for	48	h,	and	cell	viability	was	evaluated	by	hemocy-
tometer	counts.	As	shown	in	Fig.	1,	a,	β-lapachone	had	
a	marked	dose	—	dependent	inhibitory	effect	on	T24	
cell	viability.	Then	we	examined	whether	β-lapachone	
may	influence	apoptosis	of	T24	cells.	By	morphological	
analysis	with	DAPI	staining,	the	untreated	control	cells	
displayed	intact	nuclear	structures,	while	in	cells	treated	
with	β-lapachone	chromosomal	condensation	and	the	
formation	of	apoptotic	bodies	were	observed,	indicat-
ing	that	β-lapachone	induced	apoptotic	cell	death	in	a	
concentration-dependent	manner	(Fig.1,	b).
Another	hallmark	of	apoptosis	 is	degradation	of	
chromosomal	DNA	at	internucleosomal	linkages	[22].	
So,	we	analyzed	whether	DNA	 fragmentation	was	
induced	by	β-lapachone	in	T24	cells.	After	treatment	
of	T24	cells	with	β-lapachone,	a	 typical	 ladder	pat-
tern	of	internucleosomal	fragmentation	was	observed	
(Fig.	2,	a).	To	evaluate	an	apoptosis	rate,	we	analyzed	
the	amount	of	sub-G1	population	by	the	flow	cytometry	
of	fixed	nuclei.	As	shown	in	Fig.	2,	b,	the	addition	of	
β-lapachone	 to	T24	cells	 resulted	 in	a	markedly	 in-
creased	accumulation	of	cells	on	the	sub-G1	phase	in	
a	dose-dependent	manner.	These	results	suggest	that	
upon	treatment	with	β-lapachone,	T24	cells	underwent	
apoptosis,	and	that	there	is	a	good	correspondence	
between	apoptosis	rate	and	inhibition	of	cell	viability.
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Fig. 1. Viability	of	T24	cells	treated	with	β-lapachone	(1–5	µM)	
for	48	h	(a)	and	induction	of	apoptotic	bodies	(b).	(a)	Results	
are	 expressed	 as	 the	means	 ±	S.E.	 of	 three	 independent	
experiments.	 (b)	 Cells	 were	 incubated	with	 β-lapachone	
(1–5	µM)	 for	48	h.	A	number	 in	 the	 right	corner	 responds	 to	
concentration	of	β-lapachone.	Cells	were	stained	with	DAPI,	
stained	nuclei	were	observed	in	fluorescent	microscope	using	
a	blue	filter.	Magnification,	X	400		
Modulation of Bcl-2 family and activation of 
caspases by β-lapachone. Apoptotic	cell	death	 is	
known	to	be	regulated	by	pro-apoptotic	and	anti-ap-
optotic	modulators,	including	these	of	Bcl-2	family	[5,	
20].	To	analyze	whether	β-lapachone	induces	cell	death	
by	modulating	the	expression	of	Bcl-2	family	proteins,	
after	exposure	 to	different	concentrations	of	β-lapa-
chone,	total	RNAs	and	cellular	proteins	were	isolated,	
and	RT-PCR	and	 immunoblotting	were	performed.	
The	results	indicated	that	treatment	of	cells	with	β-la-
pachone	resulted	in	a	down-regulation	of	expression	
of	anti-apoptotic	Bcl-2	protein	and	up-regulation	of	
pro-apoptotic	Bax	(Fig.	3,	a	and	b).
Recent	studies	have	identified	caspases	as	impor-
tant	mediators	of	apoptosis	induced	by	various	apop-
totic	stimuli	[5,	20].	To	determine	the	role	of	caspases	
in	β-lapachone-induced	apoptosis,	we	determined	the	
levels	of	caspase-3	and	caspase-9	expression	in	T24	
cells	treated	with	β-lapachone.	As	shown	in	Fig.	4,	a,	
β-lapachone-induced	apoptosis	was	associated	with	a	
decreased	expression	of	the	pro-caspase-3	and	pro-
caspase-9	protein;	however,	we	did	not	observed	the	
active	subunits	of	both	caspases.	To	further	quantify	
the	proteolytic	activities	of	caspase-3	and	caspase-9,	
lyzates	equalized	 for	protein	 from	cells	 treated	with	
β-lapachone	were	assayed	for	in vitro	caspase-3	and	
caspase-9	activity	using	as	 substrates	DEVD-pNA	
and	 LEHD-pNA,	 respectively.	 The	 results	 showed	
that	exposure	of	cells	β-lapachone	 increased	both	
caspase-3	and	caspas-9	activity	in	a	concentration-
dependent	manner.	
	Activated	caspases	induce	a	limited	proteolysis	in	
a	number	of	cellular	proteins,	which	are	degraded	and	
have	been	used	as	a	marker	of	chemotherapy-induced	
apoptosis	[1,	9,	14].	Here,	we	examined	whether	the	
substrate	proteins	such	as	poly	(ADP-ribose)	polymer-
ase	(PARP),	phospholipase	C-γ1	(PLC-	γ1)	and	β-cate-
nin	were	cleaved	 in	cells	 treated	with	β-lapachone.	
A	dose-dependent	degradation	of	mentioned	proteins	
was	observed	 (Fig.	4,	b),	being	 in	correlation	with	
caspases	activation	upon	treatment	with	β-lapachone.	
Because	the	anti-apoptotic	 IAP	family	proteins	bind	
to	caspases	leading	to	their	inactivation	in	eukaryotic	
cells	[5,	6],	we	further	examined	the	involvement	of	
Fig. 2. Induction	of	DNA	fragmentation	(a)	and	flow	cytometry	
analysis	of	T24	cells	treated	by	β-lapachone	(1–5	µM).	(b)	Each	
point	represents	the	mean	of	two	independent	experiments
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the	IAP	family	in	β-lapachone-dependent	apoptosis.	
As	shown	in	Fig.	5,	the	levels	of	both	X-linked	inhibitor	
to	apoptosis	(XIAP)	and	cellular	inhibitor	of	apoptosis	
protein	 (cIAP)-1	expression	were	decreased	upon	
treatment	with	β-lapachone	and	cIAP-2	protein	was	
cleaved	in	a	concentration	dependent	fashion.	These	
results	suggest	that	β-lapachone-induced	apoptosis	
in	T24	cells	is	mediated,	at	least	in	part,	by	the	mito-
chondrial-signaling	pathway.	
Effects of β-lapachone on the levels of Fas and 
FasL expression. Fas/FasL	system	is	a	key	signaling	
transduction	pathway	of	apoptosis	in	cells	and	tissues	
[13,	18].	Ligation	of	Fas	by	an	agonistic	antibody	or	its	
mature	ligand	induces	receptor	oligomerization	and	for-
mation	of	death-inducing	signaling	complex,	followed	by	
activation	of	caspase-8,	with	further	activation	of	caspase	
cascade	resulting	in	cell	apoptotic	death	[5,	20].	How-
ever,	the	role	of	Fas/Fas	ligand	system	in	the	control	of	
apoptosis	in	bladder	cancer	is	controversial.	We	further	
examined	the	involvement	of	the	Fas/FasL	system	in	T24	
cells	treated	with	β-lapachone.	As	shown	in	Fig.	6,	Fas	
and	Fas-L	expression	decreased	upon	the	treatment	with	
β-lapachone	in	a	concentration	dependent	fashion.	
In	summary,	we	have	shown	here	that	β-lapachone	
induces	apoptosis	in	T24	cell	 line,	which	appears	to	
account	for	its	anti-proliferating	activity.	These	apop-
totic	mechanisms	were	mediated	by	an	activation	of	
caspases	and	an	upregulating	of	the	ratio	Bax/Bcl-2,	
and	associated	with	a	down-regulation	of	IAP	family.	
Our	study	has	demonstrated	 that	β-lapachone	may	
be	further	studied	as	a	promising	agent	for	treatment	
of	bladder	cancer.
Fig. 3. Influence	of	β-lapachone	(1–5	µM)	on	expression	of	Bcl-2	and	Bax	in	T24	cells	on	mRNA	(a)	and	protein	(b)	levels	evaluated	
by	RT-PCR	and	Western-blotting,	respectively	
Fig. 4. Activation	of	caspase-3	and	caspase-9	(a)	and	degradation	of	PARP,	PLC-γ1	and	β–catenin	protein		(b) upon	treatment	of	
T24	cells	β-lapachone	(1–5	µM).	Data	represent	the	relative	mean	values	of	two	independent	experiments	
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β-ЛАПАКОН ИНДУЦИРУЕТ ПОДАВЛЕНИЕ РОСТА И АПОПТОЗ 
ОПУХОЛЕВЫХ КЛЕТОК МОЧЕВОГО ПУЗЫРЯ ПУТЕМ 
МОДУЛЯЦИИ СЕМЕйСТВА BCL-2 И АКТИВАЦИИ КАСПАЗ
Цель: изучить механизмы апоптоза клеток карциномы мочевого пузыря человека Т24 при действии β-лапакона, хинона 
из коры дерева Tabebuia avellanedae. Материалы и методы: для определения жизнеспособности  клеток использовали 
окраску трипановым синим; окрашивание DAPI и электрофоретический анализ фрагментации ДНК в агарозном геле, 
метод проточной цитометрии (для количественной оценки апоптоза);  полимеразную цепную реакцию в режиме реального 
времени (РВ-ПЦР) и Вестерн блот-анализ (для оценки уровня экспрессии генов и белков), а также колориметрический 
анализ активности каспаз. Результаты: выявлено, что  в микромолярных концентрациях β-лапакон понижает жизне-
способность клеток линии Т24 путем активации апоптоза, что подтверждается формированием апоптотических тел и 
фрагментацией ДНК. Результаты РВ-ПЦР и иммуноблоттинга указывают на то, что обработка клеток β-лапаконом 
приводит к снижению экспрессии  Bcl-2 и к активации Bax. Апоптоз, индуцированный β-лапаконом, также сопровож-
дается активацией каспаз -3 и -9, ингибированием экспрессии семейства IAP, а также деградацией поли-(ADP-рибозо) 
полимеразы, фосфатазы C-γ1  и β-катенина.  Тем не менее, уровень экспрессии Fas и FasL снижался при увеличении 
концентрации β-лапакона. Выводы: апоптоз, индуцированный при действии β-лапакона в клетках Т24, может быть час-
тично опосредован митохондриальным сигнальным каскадом. 
Ключевые слова: β-лапакон, клетки рака мочевого пузыря линии T24, апоптоз, семейство Bcl-2, каспазы.
